Best Hospitals for Atherosclerosis Treatment in UAE

The total cost of atherosclerosis treatment depends heavily on the type and complexity of intervention required. In India, at JCI- and NABH-accredited hospitals, costs typically range from USD 3,500 to USD 18,000 — this covers single-vessel PCI with a drug-eluting stent at the lower end (~USD 3,500–6,000) through to complex multi-vessel CABG with total arterial revascularization at the upper end (~USD 12,000–18,000). In the UAE, at JCI- and DHA-accredited hospitals in Dubai or Abu Dhabi, equivalent procedures range from USD 8,000 to USD 35,000 — single-vessel PCI typically costs USD 8,000–14,000, while multi-vessel CABG ranges from USD 22,000–35,000. India therefore offers savings of approximately 50–65% compared to the UAE for the same procedures performed at comparable quality centers. These cost estimates include the surgical or catheterization procedure, anesthesia, hospital stay, standard implants (stents, grafts), ICU/HDU monitoring, and standard post-operative medications. Additional costs to budget for include pre-procedural diagnostics (coronary CT angiography, invasive angiography with FFR, echocardiography: approximately USD 500–2,000), premium implant upgrades (e.g., bioresorbable-polymer DES, IVUS/OCT imaging: USD 300–800 additional), and accommodation during the in-country recovery period. GAF Healthcare provides a fully itemized, all-inclusive cost estimate before you commit to travel, with no hidden fees.

The required in-country stay before safe international air travel depends entirely on the type of atherosclerosis intervention you undergo. For catheter-based procedures (PCI/coronary stenting, carotid artery stenting, or peripheral endovascular intervention): the hospital stay is typically 2–4 days, and most patients receive fit-to-fly clearance after a total in-country stay of 7–14 days, which allows a clinical follow-up visit at Day 7 to confirm stable hemodynamics, ECG normality, absence of stent-related complications, and satisfactory wound healing at the arterial access site. For surgical procedures (CABG, carotid endarterectomy, or peripheral arterial bypass grafting): the hospital stay is 7–10 days, followed by a mandatory in-country recovery period of 3–6 weeks before clearance for long-haul flight. This extended stay is necessary because prolonged air travel post-cardiac surgery carries elevated risks of deep vein thrombosis (DVT), pulmonary embolism, hypoxia at altitude, pleural effusion, and arrhythmia. The fit-to-fly certificate is issued by the treating cardiac or vascular surgeon only after confirming: sternal wound healing without infection or dehiscence (for CABG), absence of significant pleural effusion or pneumothorax on chest X-ray, stable cardiac rhythm, and functional exercise tolerance. GAF Healthcare arranges comfortable serviced apartment accommodation near the hospital during this entire recovery window, with regular transport to outpatient follow-up appointments and cardiac rehabilitation sessions.

Success rates for atherosclerosis treatment are measured across multiple endpoints—procedural success, freedom from major adverse cardiovascular events (MACE), and long-term survival—and vary by intervention type and patient risk profile. For PCI with contemporary drug-eluting stents (DES): procedural success rates (defined as <20% residual stenosis with TIMI 3 flow) exceed 95–98% in experienced high-volume centers. At 1 year, target lesion revascularization (TLR) rates are <5%, and MACE-free survival exceeds 90% in stable angina patients. For CABG in stable multi-vessel disease: 30-day mortality is <2% at top-tier centers (comparable to EuroSCORE II predicted risk), 5-year survival exceeds 85–90%, and freedom from re-intervention at 5 years is >85% with total arterial revascularization. For carotid endarterectomy: technical success exceeds 98%, with 30-day ipsilateral stroke risk of 1–3% at high-volume centers, and a 5-year relative risk reduction in stroke of approximately 50% compared to medical therapy alone in symptomatic patients. Partner hospitals featured in the GAF Healthcare network in both India and the UAE operate high-volume cardiovascular programs—performing 500–2,000+ cardiac procedures annually—which is independently associated with superior outcomes. These institutions hold JCI and NABH accreditations (India) or JCI and DHA/DOH accreditations (UAE), and their outcomes data are benchmarked against international registries including the American College of Cardiology's NCDR CathPCI Registry and the Society of Thoracic Surgeons (STS) database. It is important to understand that long-term success is equally dependent on lifelong adherence to guideline-directed medical therapy (statins, antiplatelets, blood pressure control, smoking cessation) and cardiac rehabilitation—areas where GAF Healthcare provides structured post-discharge support and telemedicine follow-up to ensure patients remain on track after returning home.